NEW VIDEO: The Mobilise-D Journey! BREAKING
NEWS Read more Webinar - Session 7 - Putting patients in the centre when developing digital mobility outcomes LATEST
VIDEO More Videos Frontiers An algorithm for accurate marker-based gait event detection in healthy and pathological populations during complex motor tasks Tecla Bonci, Francesca Salis, Kirsty Scott, Lisa Alcock, Clemens Becker, Stefano Bertuletti, Ellen Buckley, Marco Caruso, Andrea Cereatti, Silvia Del Din, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Walter Maetzler, Luca Palmerini, Lynn Rochester, Lars Schwickert, Basil Sharrack, Ioannis Vogiatzis, and Claudia Mazzà, on behalf of the Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Werner Remmele BREAKING
NEWS Read more Webinar - Session 7 - Putting patients in the centre when developing digital mobility outcomes LATEST
VIDEO More Videos Frontiers An algorithm for accurate marker-based gait event detection in healthy and pathological populations during complex motor tasks Tecla Bonci, Francesca Salis, Kirsty Scott, Lisa Alcock, Clemens Becker, Stefano Bertuletti, Ellen Buckley, Marco Caruso, Andrea Cereatti, Silvia Del Din, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Walter Maetzler, Luca Palmerini, Lynn Rochester, Lars Schwickert, Basil Sharrack, Ioannis Vogiatzis, and Claudia Mazzà, on behalf of the Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Mobilise-D Webinar – Putting patients in the centre when developing digital mobility outcomes BREAKING
NEWS Read more Webinar - Session 7 - Putting patients in the centre when developing digital mobility outcomes LATEST
VIDEO More Videos Frontiers An algorithm for accurate marker-based gait event detection in healthy and pathological populations during complex motor tasks Tecla Bonci, Francesca Salis, Kirsty Scott, Lisa Alcock, Clemens Becker, Stefano Bertuletti, Ellen Buckley, Marco Caruso, Andrea Cereatti, Silvia Del Din, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Walter Maetzler, Luca Palmerini, Lynn Rochester, Lars Schwickert, Basil Sharrack, Ioannis Vogiatzis, and Claudia Mazzà, on behalf of the Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Grosshansdorf is the first Mobilise-D site to reach their target number of participants in the Clinical Validation Study BREAKING
NEWS Read more Webinar - Session 7 - Putting patients in the centre when developing digital mobility outcomes LATEST
VIDEO More Videos Frontiers An algorithm for accurate marker-based gait event detection in healthy and pathological populations during complex motor tasks Tecla Bonci, Francesca Salis, Kirsty Scott, Lisa Alcock, Clemens Becker, Stefano Bertuletti, Ellen Buckley, Marco Caruso, Andrea Cereatti, Silvia Del Din, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Walter Maetzler, Luca Palmerini, Lynn Rochester, Lars Schwickert, Basil Sharrack, Ioannis Vogiatzis, and Claudia Mazzà, on behalf of the Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Falling down is easy, getting up is difficult BREAKING
NEWS Read more Webinar - Session 7 - Putting patients in the centre when developing digital mobility outcomes LATEST
VIDEO More Videos Frontiers An algorithm for accurate marker-based gait event detection in healthy and pathological populations during complex motor tasks Tecla Bonci, Francesca Salis, Kirsty Scott, Lisa Alcock, Clemens Becker, Stefano Bertuletti, Ellen Buckley, Marco Caruso, Andrea Cereatti, Silvia Del Din, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Walter Maetzler, Luca Palmerini, Lynn Rochester, Lars Schwickert, Basil Sharrack, Ioannis Vogiatzis, and Claudia Mazzà, on behalf of the Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA A new Mobilise-D scoping review: The clinical utility of digital mobility outcomes BREAKING
NEWS Read more Webinar - Session 7 - Putting patients in the centre when developing digital mobility outcomes LATEST
VIDEO More Videos Frontiers An algorithm for accurate marker-based gait event detection in healthy and pathological populations during complex motor tasks Tecla Bonci, Francesca Salis, Kirsty Scott, Lisa Alcock, Clemens Becker, Stefano Bertuletti, Ellen Buckley, Marco Caruso, Andrea Cereatti, Silvia Del Din, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Walter Maetzler, Luca Palmerini, Lynn Rochester, Lars Schwickert, Basil Sharrack, Ioannis Vogiatzis, and Claudia Mazzà, on behalf of the Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

About Us

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

About Us

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

About Us

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed

Mobilise-D @Mobilise_D

📢NEW VIDEO: The Mobilise-D Journey📢

Watch how Mobilise-D develops innovative digital technology to measure mobility in daily life, thereby transforming clinical research and contributing to personalised health👇🤩

🔗 https://t.co/7BJfy33xe2

#MobiliseD @IHIEurope @EFPIA
View on Twitter
5
6
Mobilise-D @Mobilise_D

✨Free webinar about connected health devices✨
@LynnRochester1 will have a presentation and join the “Panel discussion: what have we learned so far? How can experience lead us to design more usable and effective solutions?” 📅June 30⌚️10-13 BST
https://t.co/RIdcw7A8zB @IHIEurope
View on Twitter
7
10

Latest News

NEW VIDEO: The Mobilise-D Journey!

We are three-and-a-half years into Mobilise-D, and what a journey we have had together! The results of the Technical Validation Study are excellent, while recruitment of participants in the Clinical Validation Study has passed well over 2000 and is getting close to 90% of our target. Data sharing solutions are underway, and future interactions with…

Read more

Upcoming Events

No event found!
Sign up for our Newsletter!